A strongly worded opinion piece in The British Medical Journal argues that evidence-based medicine has been corrupted. Specifically, the editorial piece argues that the pharmaceutical industry’s responsibility to its shareholders means that priority must be given to their hierarchical power structures, product loyalty, and public relations propaganda over scientific integrity.